American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78. doi: 10.4158/ep.18.s1.1.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Atherosclerosis / economics
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control*
  • Child
  • Combined Modality Therapy / economics
  • Cost Savings
  • Diet, Fat-Restricted
  • Drug Monitoring
  • Dyslipidemias / economics
  • Dyslipidemias / metabolism
  • Dyslipidemias / physiopathology
  • Dyslipidemias / therapy*
  • Female
  • Health Care Costs
  • Humans
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / economics
  • Hypolipidemic Agents / therapeutic use
  • Insulin Resistance
  • Lipids / blood
  • Male
  • Motor Activity
  • Risk Factors
  • Smoking Cessation
  • United States / epidemiology

Substances

  • Hypolipidemic Agents
  • Lipids